Federal Register / Vol. 88, No. 191 / Wednesday, October 4, 2023 / Notices 68671 

1A record of the Commissioners’ votes, the 

Commission’s statement on adequacy, and any 

individual Commissioner’s statements will be 

available from the Office of the Secretary and at the 

Commission’s website. 

2Chairman David S. Johanson and Commissioner 

Rhonda K. Schmidtlein voted to conduct full a 

review. 

3The Commission has found the responses 

submitted on behalf of ADA Carbon Solutions, LLC, 

Calgon Carbon Corporation, Carbon Activated 

Corporation, Jacobi Carbons, Inc., and Norit 

Americas, Inc. to be individually adequate. 

Comments from other interested parties will not be 

accepted (see 19 CFR 207.62(d)(2)). 

DATES: September 5, 2023. 

FOR FURTHER INFORMATION CONTACT: 

Kenneth Gatten III (202–708–1447), 

Office of Investigations, U.S. 

International Trade Commission, 500 E 

Street SW, Washington, DC 20436. 

Hearing-impaired persons can obtain 

information on this matter by contacting 

the Commission’s TDD terminal on 202– 

205–1810. Persons with mobility 

impairments who will need special 

assistance in gaining access to the 

Commission should contact the Office 

of the Secretary at 202–205–2000. 

General information concerning the 

Commission may also be obtained by 

accessing its internet server (https://

www.usitc.gov). The public record for 

this proceeding may be viewed on the 

Commission’s electronic docket (EDIS) 

at https://edis.usitc.gov. 

SUPPLEMENTARY INFORMATION: 

Background.—On September 5, 2023, 

the Commission determined that the 

domestic interested party group 

response to its notice of institution (88 

FR 35926, June 1, 2023) of the subject 

five-year review was adequate and that 

the respondent interested party group 

response was inadequate. The 

Commission did not find any other 

circumstances that would warrant 

conducting a full review.1 Accordingly, 

the Commission determined that it 

would conduct an expedited review 

pursuant to section 751(c)(3) of the Act 

(19 U.S.C. 1675(c)(3)).2

For further information concerning 

the conduct of this review and rules of 

general application, consult the 

Commission’s Rules of Practice and 

Procedure, part 201, subparts A and B 

(19 CFR part 201), and part 207, 

subparts A, D, E, and F (19 CFR part 

207). 

Staff report.—A staff report 

containing information concerning the 

subject matter of the review has been 

placed in the nonpublic record, and will 

be made available to persons on the 

Administrative Protective Order service 

list for this review on October 18, 2023. 

A public version will be issued 

thereafter, pursuant to § 207.62(d)(4) of 

the Commission’s rules. 

Written submissions.—As provided in 

§ 207.62(d) of the Commission’s rules, 

interested parties that are parties to the 

review and that have provided 

individually adequate responses to the 

notice of institution,3 and any party 

other than an interested party to the 

review may file written comments with 

the Secretary on what determination the 

Commission should reach in the review. 

Comments are due on or before 5:15 

p.m. on October 26, 2023, and may not 

contain new factual information. Any 

person that is neither a party to the fiveyear review nor an interested party may 

submit a brief written statement (which 

shall not contain any new factual 

information) pertinent to the review by 

October 26, 2023. However, should the 

Department of Commerce (‘‘Commerce’’) 

extend the time limit for its completion 

of the final results of its review, the 

deadline for comments (which may not 

contain new factual information) on 

Commerce’s final results is three 

business days after the issuance of 

Commerce’s results. If comments 

contain business proprietary 

information (BPI), they must conform 

with the requirements of §§ 201.6, 

207.3, and 207.7 of the Commission’s 

rules. The Commission’s Handbook on 

Filing Procedures, available on the 

Commission’s website at https://

www.usitc.gov/documents/handbook_

on_filing_procedures.pdf, elaborates 

upon the Commission’s procedures with 

respect to filings. 

In accordance with §§ 201.16(c) and 

207.3 of the rules, each document filed 

by a party to the review must be served 

on all other parties to the review (as 

identified by either the public or BPI 

service list), and a certificate of service 

must be timely filed. The Secretary will 

not accept a document for filing without 

a certificate of service. 

Determination.—The Commission has 

determined this review is 

extraordinarily complicated and 

therefore has determined to exercise its 

authority to extend the review period by 

up to 90 days pursuant to 19 U.S.C. 

1675(c)(5)(B). 

Authority: This review is being 

conducted under authority of title VII of 

the Act; this notice is published 

pursuant to § 207.62 of the 

Commission’s rules. 

By order of the Commission. 

Issued: September 29, 2023. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2023–22065 Filed 10–3–23; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1275] 

Importer of Controlled Substances 

Application: Fisher Clinical Services, 

Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Fisher Clinical Services, Inc. 

has applied to be registered as an 

importer of basic class(es) of controlled 

substance(s). Refer to SUPPLEMENTARY

INFORMATION listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before November 3, 2023. Such 

persons may also file a written request 

for a hearing on the application on or 

before November 3, 2023. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on August 15, 2023, Fisher 

Clinical Services, Inc., 700A–C Nestle 

Way, Breinigsville, Pennsylvania 

18031–1522, applied to be registered as 

an importer of the following basic 

class(es) of controlled substance(s): 


lotter on DSK11XQN23PROD with NOTICES1
68672 Federal Register / Vol. 88, No. 191 / Wednesday, October 4, 2023 / Notices 

Controlled substance Drug code Schedule 

Marihuana Extract ...... 7350 I 

Psilocybin ................... 7437 I 

Methylphenidate ......... 1724 II 

Levorphanol ............... 9220 II 

Noroxymorphone ....... 9668 II 

Tapentadol ................. 9780 II 

The company plans to import the 

listed controlled substances for use in 

clinical trials only. No other activities 

for these drug codes are authorized for 

this registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Claude Redd, 

Acting Deputy Assistant Administrator. 

[FR Doc. 2023–21972 Filed 10–3–23; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Notice of Lodging of Proposed 

Consent Decree 

In accordance with Departmental 

Policy, 28 CFR 50.7, section 122(d)(2) of 

the Comprehensive Environmental 

Response, Compensation, and Liability 

Act (‘‘CERCLA’’), 42 U.S.C. 9622(d)(2), 

and Paragraph 4.1 of the underlying 

Consent Decree, notice is hereby given 

that a proposed Amendment to the 

Consent Decree in United States v. Shell 

Oil. Co., Case No. 83-cv-2379, was 

lodged with the United States District 

Court for the District of Colorado on 

September 28, 2023. 

Previously, a Consent Decree 

resolving claims under CERCLA related 

to the former Rocky Mountain Arsenal 

outside of Denver, Colorado between the 

parties was entered in this case on 

February 12, 1993. That Consent Decree 

incorporated a February 12, 1989, 

Settlement Agreement between the 

United States and Shell Oil. Under the 

Consent Decree, the Army and Shell Oil 

are obligated to pay the Environmental 

Protection Agency’s CERCLA oversight 

costs for Army-led environmental 

cleanup activities at the Rocky 

Mountain Arsenal. The proposed 

Amendment to the Consent Decree 

changes the manner in which the 

Environmental Protection Agency’s 

CERCLA oversight costs will be paid, 

and fully resolves those costs. 

The Department of Justice will accept 

written comments relating to this 

proposed Amendment to the Consent 

Decree for thirty (30) days from the date 

of publication of this Notice. Please 

address comments to Phillip R. Dupre ́, 

Post Office Box 7611, Washington, DC 

20044 and/or pubcomment_eds.enrd@

usdoj.gov and refer to United States v. 

Shell Oil Co., DJ No. 90–11–6–21352. 

The proposed Amendment to the 

Consent Decree may be examined at the 

Clerk’s Office, United States District 

Court for the District of Colorado, 901 

19th Street, Denver, CO 80294. In 

addition, the proposed Consent Decree 

may be examined electronically at 

https://www.justice.gov/enrd/consentdecrees. 

Cherie Rogers, 

Assistant Section Chief, Environmental 

Defense Section, Environment and Natural 

Resources Division. 

[FR Doc. 2023–21961 Filed 10–3–23; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Notice of Lodging of Proposed 

Consent Decree 

In accordance with Departmental 

Policy, 28 CFR 50.7, notice is hereby 

given that a proposed Consent Decree in 

United States, et al. v. Waco Oil & Gas 

Co., Inc., Civil Action No. 23–cv–00078, 

was lodged with the United States 

District Court for the Northern District 

of West Virginia on September 28, 2023. 

This proposed Consent Decree 

concerns a complaint filed by the 

United States and the State of West 

Virginia against Defendant Waco Oil & 

Gas Co., Inc., pursuant to Section 309(b) 

and (d) of the Clean Water Act, 33 

U.S.C. 1319(b) and (d), to obtain 

injunctive relief from and impose civil 

penalties against the Defendant for 

violating the Clean Water Act by 

discharging pollutants without a permit 

into waters of the United States. The 

proposed Consent Decree resolves these 

allegations by requiring the Defendant 

to restore impacted areas, perform 

mitigation, and pay a civil penalty. 

The Department of Justice will accept 

written comments relating to this 

proposed Consent Decree for thirty (30) 

days from the date of publication of this 

Notice. Please address comments by 

email to pubcomment_eds.enrd@

usdoj.gov or by mail to Albert Lin, 

Environment and Natural Resources 

Division, Environmental Defense 

Section, Post Office Box 7611, 

Washington, DC 20044–7611; and refer 

to United States, et al. v. Waco Oil & 

Gas Co., Inc., DJ No. 90–5–1–1–22046. 

The proposed Consent Decree may be 

examined at the Clerk’s Office, United 

States District Court for the Northern 

District of West Virginia, located at 500 

West Pike Street, Room 301, Clarksburg, 

WV 26301. In addition, the proposed 

Consent Decree may be examined 

electronically at https://

www.justice.gov/enrd/consent-decrees. 

Cherie Rogers, 

Assistant Section Chief, Environmental 

Defense Section, Environment and Natural 

Resources Division. 

[FR Doc. 2023–21966 Filed 10–3–23; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

[OMB Number 1105–0109] 

Agency Information Collection 

Activities; Proposed eCollection 

eComments Requested; Procurement 

Collusion Strike Force Complaint Form 

AGENCY: Antitrust Division, Department 

of Justice. 

ACTION: 30-Day notice. 

SUMMARY: The Antitrust Division, 

Department of Justice (DOJ), will be 

submitting the following information 

collection request to the Office of 

Management and Budget (OMB) for 

review and approval in accordance with 

the Paperwork Reduction Act of 1995. 

The proposed information collection 

was previously published in the Federal 

Register on August 1, 2023, allowing a 

60-day comment period. 

DATES: Comments are encouraged and 

will be accepted for 30 days until 

November 3, 2023. 

FOR FURTHER INFORMATION CONTACT: If 

you have comments especially on the 

estimated public burden or associated 

response time, suggestions, or need a 

copy of the proposed information 

collection instrument with instructions 

or additional information, please 

contact: sarah.oldfield@usdoj.gov; 

telephone: 202–305–8915. 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 


lotter on DSK11XQN23PROD with NOTICES1